Macrophage subtype predicts lymph node metastasis in oesophageal adenocarcinoma and promotes cancer cell invasion in vitro

British Journal of Cancer

Volumn 113, Issue 5, 2015, Pages 738-746

  Cao, Wenqing ^a   Peters, Jeffrey H ^b   Nieman, Dylan ^b   Sharma, Meenal ^b   Watson, Thomas ^b   Yu, Jiangzhou ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

lymph node metastasis; macrophage; oesophageal adenocarcinoma; polarisation; prognosis

Indexed keywords

CD163 ANTIGEN; CD40 ANTIGEN; CD68 ANTIGEN;

ADJUVANT THERAPY; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC VESSEL DENSITY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; ADENOCARCINOMA; ADULT; CELL MOTION; ESOPHAGUS TUMOR; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY; TUMOR CELL LINE; TUMOR INVASION; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; CELL LINE, TUMOR; CELL MOVEMENT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MACROPHAGES; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; YOUNG ADULT;

EID: 84940794314     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.292     Document Type: Article

References (47)

1. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, HofstetterWL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese Jr TK, Warren G, Washington MK, Willett C, Wright CD. National Comprehensive Cancer Network (2011) Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 9(8): 830-887.
2. Aron-Wisnewsky J, Tordjman J, Poitou C, Darakhshan F, HugolD, Basdevant A, Aissat A, Guerre-Millo M, Clément K (2009) Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 94(11): 4619-4623.
3. Bollschweiler E, Baldus SE, Schroder W, Schneider PM, Holscher AH (2006) Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol 94(5): 355-363.
4. Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100(16): 1184-1187.
5. Campbell NP, Villaflor VM (2010) Neoadjuvant treatment of esophageal cancer. World J Gastroenterol 16(30): 3793-3803.
6. Coffelt SB, Hughes R, Lewis CE (2009) Tumor-associated macrophages: effectors of angiogenesis and tumor progression. Biochim Biophys Acta 1796(1): 11-18.
7. Colleypriest BJ, Ward SG, Tosh D (2009) How does inflammation cause Barrett's metaplasia? Curr Opin Pharmacol 9(6): 721-726.
8. Cook MB, Chow WH, Devesa SS (2009) Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer 101(5): 855-859.
9. Cui YL, Li HK, Zhou HY, Zhang T, Li Q (2013) Correlations of tumorassociated macrophage subtypes with liver metastases of colorectal cancer. Asian Pac J Cancer Prev 14(2): 1003-1007.
10. De Palma M, Lewis CE (2013) Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell 23(3): 277-286.
11. Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N, Descamps P, Gamelin E, Gascan H, Hebbar M, Jeannin P (2007) Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110(13): 4319-4330.
12. Durafourt BA, Moore CS, Zammit DA, Johnson TA, Zaguia F, Guiot MC, Bar-Or A, Antel JP (2012) Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60(5): 717-727.
13. Edin S, Wikberg ML, Dahlin AM, Rutegard J, Oberg A, Oldenborg PA, Palmqvist R (2012) The distribution of macrophages with a M1 or M2 phenotype in relation to prognosis and the molecular characteristics of colorectal cancer. PLoS ONE 7(10): e47045.
14. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5(12): 953-964.
15. Guo SJ, Lin DM, Li J, Liu RZ, Zhou CX, Wang DM, Ma WB, Zhang YH, Zhang SR (2007) Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma. Dis Esophagus 20(2): 107-116.
16. Horimoto Y, Polanska UM, Takahashi Y, Orimo A (2012) Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr 6(3): 193-202.
17. Kim S, Takahashi H, Lin WW, Descargues P, Grivennikov S, Kim Y, Luo JL, Karin M (2009a) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457(7225): 102-106.
18. Kim TJ, Kim HY, Lee KW, Kim MS (2009b) Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics 29(2): 403-421.
19. Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S (2004) Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99(9): 1667-1674.
20. Kong LQ, Zhu XD, Xu HX, Zhang JB, Lu L, Wang WQ, Zhang QB, Wu WZ, Wang L, Fan J, Tang ZY, Sun HC (2013) The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. PLoS ONE 8(3): e59771.
21. Kurahara H, Shinchi H, Mataki Y, Maemura K, Noma H, Kubo F, Sakoda M, Ueno S, Natsugoe S, Takao S (2011) Significance of M2-polarized tumorassociated macrophage in pancreatic cancer. J Surg Res 167(2): e211-e219.
22. Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y, Hao H, Tang K, Yi P, Liu M, Miao S, Ye D (2011) Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2. Oncogene 30(36): 3887-3899.
23. Ma J, Liu L, Che G, Yu N, Dai F, You Z (2010) The M1 form of tumorassociated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 10: 112.
24. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13(7): 265-270.
25. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22(2): 231-237.
26. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11): 549-555.
27. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12): 958-969.
28. Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, Mathé EA, Kumamoto K, Zhao Y, Budhu A, Hagiwara N, Wang XW, Miyashita M, Casson AG, Harris CC (2010) Inflammatory and microRNA gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res 16(23): 5824-5834.
29. Noguchi T, Takeno S, Shibata T, Uchida Y, Yokoyama S, Muller W (2002) VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus. Oncol Rep 9(5): 995-999.
30. Ohashi Y, Ishibashi S, Suzuki T, Shineha R, Moriya T, Satomi S, Sasano H (2000) Significance of tumor associated tissue eosinophilia and other inflammatory cell infiltrate in early esophageal squamous cell carcinoma. Anticancer Res 20(5A): 3025-3030.
31. Pantano F, Berti P, Guida FM, Perrone G, Vincenzi B, Amato MM, Righi D, Dell'aquila E, Graziano F, Catalano V, Caricato M, Rizzo S, Muda AO, Russo A, Tonini G, Santini D (2013) The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients. J Cell Mol Med 17(11): 1415-1421.
32. Pechkovsky DV, Prasse A, Kollert F, Engel KM, Dentler J, Luttmann W, Friedrich K, Müller-Quernheim J, Zissel G (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 137(1): 89-101.
33. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4(1): 71-78.
34. Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1): 39-51.
35. Ren B, Zakharov V, Yang Q, McMahon L, Yu J, Cao W (2013) MACC1 is related to colorectal cancer initiation and early-stage invasive growth. Am J Clin Pathol 140(5): 701-707.
36. Saad RS, Kordunsky L, Liu YL, Denning KL, Kandil HA, Silverman JF (2006) Lymphatic microvessel density as prognostic marker in colorectal cancer. Mod Pathol 19(10): 1317-1323.
37. Sepesi B, Watson TJ, Zhou D, Polomsky M, Litle VR, Jones CE, Raymond DP, Hu R, Qiu X, Peters JH (2010) Are endoscopic therapies appropriate for superficial submucosal esophageal adenocarcinoma? An analysis of esophagectomy specimens. J Am Coll Surg 210(4): 418-427.
38. Shabo I, Olsson H, Sun XF, Svanvik J (2009) Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer 125(8): 1826-1831.
39. Shigeoka M, Urakawa N, Nakamura T, Nishio M, Watajima T, Kuroda D, Komori T, Kakeji Y, Semba S, Yokozaki H (2013) Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci 104(8): 1112-1119.
40. Sica A, Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122(3): 787-795.
41. Steevens J, Botterweck AA, Dirx MJ, van den Brandt PA, Schouten LJ (2010) Trends in incidence of oesophageal and stomach cancer subtypes in Europe. Eur J Gastroenterol Hepatol 22(6): 669-678.
42. Stewart DA, Yang Y, Makowski L, Troester MA (2012) Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages. Mol Cancer Res 10(6): 727-738.
43. Stiles BM, Mirza F, Coppolino A, Port JL, Lee PC, Paul S, Altorki NK (2011) Clinical T2-T3N0M0 esophageal cancer: the risk of node positive disease. Ann Thorac Surg 92(2): 491-496; discussion 496-498.
44. Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y (2010) Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res 20(6): 701-712.
45. Ward SG, Mrsny R (2009) New insights into mechanisms of gastrointestinal inflammation and cancer. Curr Opin Pharmacol 9(6): 677-679.
46. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW (2007) An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg 245(5): 717-725.
47. Zhang JQ, Hooker CM, Brock MV, Shin J, Lee S, How R, Franco N, Prevas H, Hulbert A, Yang SC (2012) Neoadjuvant chemoradiation therapy is beneficial for clinical stage T2 N0 esophageal cancer patients due to inaccurate preoperative staging. Ann Thorac Surg 93(2): 429-435; discussion 436-427.